Immediately, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a call memo permitting Novavax monovalent COVID-19 boosters for adults.

This motion offers individuals ages 18 years and older the choice to obtain a Novavax monovalent booster as an alternative of an up to date (bivalent) Pfizer-BioNTech or Moderna booster if they’ve accomplished major collection vaccination however haven’t beforehand obtained a COVID-19 booster-;and if they can’t or won’t obtain mRNA vaccines.

Some could also be unable to obtain an mRNA vaccine because of an allergy to a part of an mRNA COVID-19 vaccine, or because of a historical past of a extreme allergic response (reminiscent of anaphylaxis) after a earlier dose of an mRNA COVID-19 vaccine, or an absence of availability of an mRNA vaccine. Individuals ages 18 and older can also select to obtain a Novavax monovalent booster if they’re unwilling to obtain mRNA vaccines, and would in any other case not obtain a booster dose.

FDA’s authorization of monovalent COVID-19 boosters and CDC’s suggestion to be used, are vital steps ahead in our nation’s complete vaccination program-;a program that has helped present elevated safety for all People in opposition to COVID-19 illness and dying.